Event Brief
Chinese Biotech Deals Surge with US$1.2B Pact
Filed: Feb 23, 2026 at 3:04 AM ET
Summary: Harbour BioMed partners with Solstice Oncology for a US$1.2 billion deal to develop an antibody outside China.
WHO: Harbour BioMed, Solstice Oncology
WHAT: Partnership for antibody development and commercialization
WHEN: Feb 22, 2026 at 7:00 PM ET
WHERE: Shanghai
WHY: To secure international partnerships and licensing fees
ℹ️ This event is analyzed using pattern arcs, velocity indicators, and source analysis in our MI Console.
Know more. Read less.
The BriefBrief follows the story, so you don't have to read every article. See what happened, how it changed, and where it came from, all in one place.
Same format. Every time.
See how stories unfold →